2023
Vitamin D and infertility
Simpson S, Pal L. Vitamin D and infertility. Current Opinion In Obstetrics & Gynecology 2023, 35: 300-305. PMID: 37266579, DOI: 10.1097/gco.0000000000000887.Peer-Reviewed Original ResearchConceptsPolycystic ovarian syndromeVitamin DGynaecological disordersVitamin D serum levelsOvarian reserve parametersD serum levelsVitamin D deficiencyVitamin D statusDiminished ovarian reserveCommon gynaecological disorderReproductive health burdenHigher pregnancy rateD deficiencyD statusOvarian reserveOvarian syndromeInfertile womenSerum levelsUterine myomaMenstrual regularityEndometriosis patientsInsulin levelsUterine fibroidsHealth burdenPregnancy rateTestosterone effects on autonomic function in women with androgen excess polycystic ovary syndrome
Stone T, Cardozo L, Oluwatade T, Leone C, Okifo F, Reckelhoff J, Pal L, Stachenfeld N. Testosterone effects on autonomic function in women with androgen excess polycystic ovary syndrome. Physiology 2023, 38: 5729543. DOI: 10.1152/physiol.2023.38.s1.5729543.Peer-Reviewed Original ResearchLower body negative pressureBlood pressureHormone interventionSympathetic baroreflexAutonomic functionSimilar systolic blood pressureGonadotropin-releasing hormone antagonistInsulin-resistant womenDiastolic blood pressurePolycystic ovary syndromeSystolic blood pressureCardiovascular autonomic controlBody negative pressureMSNA activitySerum angiotensinOvarian syndromeOvary syndromeResistant womenBaroreflex sensitivityHormone suppressionSerum aldosteroneAutonomic perturbationsT elevationHormone antagonistElevated androgens
2018
Polycystic ovarian syndrome
Pal L, Pathy S. Polycystic ovarian syndrome. 2018, 117-129. DOI: 10.1002/9781119072980.ch12.ChaptersPolycystic ovarian syndromeOvulatory dysfunctionOvarian syndromeRisk of complicationsOverall health riskNeonatal complicationsGestational diabetesAndrogen excessCesarean sectionFetal macrosomiaOperative deliveryPolycystic ovariesClinical manifestationsTreatment modalitiesMetabolic disordersDiagnostic criteriaBody hairLaboratory evaluationWomenComplicationsDysfunctionIndividual womenUnique risksSyndromeRisk
2015
Management options and fertility‐preserving therapy for premenopausal endometrial hyperplasia and early‐stage endometrial cancer
Gressel GM, Parkash V, Pal L. Management options and fertility‐preserving therapy for premenopausal endometrial hyperplasia and early‐stage endometrial cancer. International Journal Of Gynecology & Obstetrics 2015, 131: 234-239. PMID: 26384790, DOI: 10.1016/j.ijgo.2015.06.031.Peer-Reviewed Original ResearchConceptsEarly-stage endometrial cancerEndometrial cancerEndometrial hyperplasiaFertility preservationFuture fertilityRisk factorsComplex atypical endometrial hyperplasiaEndometrial hyperplasia/cancerType 2 diabetes mellitusFertility-preserving therapyAtypical endometrial hyperplasiaPolycystic ovarian syndromeChronic anovulationLifestyle modificationPremenopausal womenConservative managementOvarian syndromeDefinitive managementDiabetes mellitusEndometrial pathologyGlycemic controlMetabolic syndromeDATA COLLECTIONCochrane DatabaseInsulin resistance